Núria López-Bigas receives 2026 ASEICA Women Award for her career in cancer genomics

The IRB Barcelona researcher is recognized for her scientific career and for promoting visibility for women in oncology research.

Generic image of a microscope with blurred cells in the background.
AI

Generic image of a microscope with blurred cells in the background.

Dr. Núria López-Bigas, ICREA Research Professor at IRB Barcelona, has been honored with the 2026 ASEICA Women Award. The Spanish Association for Cancer Research (ASEICA) recognizes her scientific career in cancer genomics and her role as a female role model in oncology research.

The award highlights López-Bigas's work leading the Biomedical Genomics laboratory, which merges biology and bioinformatics to study the genetic mechanisms of cancer. Her research has been crucial in identifying genes and mutations responsible for tumor development and understanding the processes driving genetic alterations.
An international reference in cancer genomics, Dr. López-Bigas has been a member of the European Molecular Biology Organization (EMBO) since 2016 and the Royal Spanish Academy of Sciences since 2024. In 2022, she received the ISCB Innovator Award. She currently leads the European project CGI-Clinics, aimed at improving tumor genome interpretation for clinical decision-making, and co-leads PROMINENT, an international initiative investigating the mechanisms driving cancer development and evolution.
“

"Núria López-Bigas is one of the leading figures in oncology research in our country. Her contributions to cancer genomics have been fundamental to better understanding the mechanisms that drive tumor development and advancing toward more precise oncology. With this award, we want to recognize not only her scientific excellence and international projection, but also her role in giving visibility to women in oncology research. Careers like hers are essential to continue moving toward science with equal opportunities."

Rafael López · President of ASEICA
In the same awards edition, ASEICA also presented the ASEICA Young Investigator Award in Basic Research to Dr. Francisco Martínez-Jiménez, a former member of Dr. López-Bigas’s laboratory who now leads the Computational Immunogenomics Lab at the Vall d'Hebron Institute of Oncology (VHIO), for his work on tumor evolution, metastasis, and response to immunotherapy.
Additionally, Dr. Andrés Cervantes (Scientific Director of INCLIVA and Head of the Medical Oncology Department at Hospital Clínico Universitario de Valencia) was recognized with the 2026 ASEICA Cancer Research Award; Dr. Rodrigo Sánchez-Bayona (medical oncologist at Hospital Universitario 12 de Octubre in Madrid) with the Young Investigator Award in Clinical Research; and the Spanish Association of Metastatic Breast Cancer (AECMM) with the Social Commitment Award.
The awards ceremony will take place during the 21st ASEICA International Congress, to be held in Seville from 25 to 27 November.
About IRB Barcelona: The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
Based on information from the official source: IRB Barcelona - Institut de Recerca Biomèdica (18/11/2026)